Nanosphere's Verigene® Blood Culture Assay to Detect Multidrug-Resistant Gram-Negative Bacterial Outbreak: A Prospective Study on 79 Hematological Patients in a Country with High Prevalence of Antimicrobial Resistance

Infections are a major cause of morbidity and mortality in hematological patients. We prospectively tested a new molecular assay (Verigene®) in 79 consecutive hematological patients, with sepsis by gram-negative bacteria. A total of 82 gram-negative microorganisms were isolated by blood cultures, of...

Full description

Bibliographic Details
Main Authors: Raffaella Greco, Maria Chiara Barbanti, Nicasio Mancini, Laura Infurnari, Renée Pasciuta, Alessandra Forcina, Chiara Oltolini, Gabriele Casirati, Daniele Mannina, Fabio Giglio, Carlo Messina, Mara Morelli, Francesca Lorentino, Sara Mastaglio, Tommaso Perini, Luca Vago, Paolo Scarpellini, Matteo Giovanni Carrabba, Maria Teresa Lupo Stanghellini, Sarah Marktel, Andrea Assanelli, Massimo Bernardi, Consuelo Corti, Jacopo Peccatori, Massimo Clementi, Fabio Ciceri
Format: Article
Language:English
Published: SAABRON PRESS 2019-06-01
Series:Clinical Hematology International
Subjects:
Online Access:https://www.atlantis-press.com/article/125907527/view
_version_ 1797229387301519360
author Raffaella Greco
Maria Chiara Barbanti
Nicasio Mancini
Laura Infurnari
Renée Pasciuta
Alessandra Forcina
Chiara Oltolini
Gabriele Casirati
Daniele Mannina
Fabio Giglio
Carlo Messina
Mara Morelli
Francesca Lorentino
Sara Mastaglio
Tommaso Perini
Luca Vago
Paolo Scarpellini
Matteo Giovanni Carrabba
Maria Teresa Lupo Stanghellini
Sarah Marktel
Andrea Assanelli
Massimo Bernardi
Consuelo Corti
Jacopo Peccatori
Massimo Clementi
Fabio Ciceri
author_facet Raffaella Greco
Maria Chiara Barbanti
Nicasio Mancini
Laura Infurnari
Renée Pasciuta
Alessandra Forcina
Chiara Oltolini
Gabriele Casirati
Daniele Mannina
Fabio Giglio
Carlo Messina
Mara Morelli
Francesca Lorentino
Sara Mastaglio
Tommaso Perini
Luca Vago
Paolo Scarpellini
Matteo Giovanni Carrabba
Maria Teresa Lupo Stanghellini
Sarah Marktel
Andrea Assanelli
Massimo Bernardi
Consuelo Corti
Jacopo Peccatori
Massimo Clementi
Fabio Ciceri
author_sort Raffaella Greco
collection DOAJ
description Infections are a major cause of morbidity and mortality in hematological patients. We prospectively tested a new molecular assay (Verigene®) in 79 consecutive hematological patients, with sepsis by gram-negative bacteria. A total of 82 gram-negative microorganisms were isolated by blood cultures, of which 76 cases were mono-microbial. Considering the bacteria detectable by the system, the concordance with standard blood cultures was 100%. Resistance genes were detected in 20 of the isolates and 100% were concordant with the phenotypic antibiotic resistance. Overall, this new assay correctly identified 66/82 of all the gram-negative pathogens, yielding a general sensitivity of 80.5%, and providing information on genetic antibiotic resistance in a few hours. This new molecular assay could ameliorate patient management, resulting in a more rational use of antibiotics.
first_indexed 2024-04-24T15:11:47Z
format Article
id doaj.art-7ed8670b646b4b228c6da20932894498
institution Directory Open Access Journal
issn 2590-0048
language English
last_indexed 2024-04-24T15:11:47Z
publishDate 2019-06-01
publisher SAABRON PRESS
record_format Article
series Clinical Hematology International
spelling doaj.art-7ed8670b646b4b228c6da209328944982024-04-02T10:49:23ZengSAABRON PRESSClinical Hematology International2590-00482019-06-011210.2991/chi.d.190321.001Nanosphere's Verigene® Blood Culture Assay to Detect Multidrug-Resistant Gram-Negative Bacterial Outbreak: A Prospective Study on 79 Hematological Patients in a Country with High Prevalence of Antimicrobial ResistanceRaffaella GrecoMaria Chiara BarbantiNicasio ManciniLaura InfurnariRenée PasciutaAlessandra ForcinaChiara OltoliniGabriele CasiratiDaniele ManninaFabio GiglioCarlo MessinaMara MorelliFrancesca LorentinoSara MastaglioTommaso PeriniLuca VagoPaolo ScarpelliniMatteo Giovanni CarrabbaMaria Teresa Lupo StanghelliniSarah MarktelAndrea AssanelliMassimo BernardiConsuelo CortiJacopo PeccatoriMassimo ClementiFabio CiceriInfections are a major cause of morbidity and mortality in hematological patients. We prospectively tested a new molecular assay (Verigene®) in 79 consecutive hematological patients, with sepsis by gram-negative bacteria. A total of 82 gram-negative microorganisms were isolated by blood cultures, of which 76 cases were mono-microbial. Considering the bacteria detectable by the system, the concordance with standard blood cultures was 100%. Resistance genes were detected in 20 of the isolates and 100% were concordant with the phenotypic antibiotic resistance. Overall, this new assay correctly identified 66/82 of all the gram-negative pathogens, yielding a general sensitivity of 80.5%, and providing information on genetic antibiotic resistance in a few hours. This new molecular assay could ameliorate patient management, resulting in a more rational use of antibiotics.https://www.atlantis-press.com/article/125907527/viewSepsisHematological patientsMolecular diagnosisCarbapenem resistance
spellingShingle Raffaella Greco
Maria Chiara Barbanti
Nicasio Mancini
Laura Infurnari
Renée Pasciuta
Alessandra Forcina
Chiara Oltolini
Gabriele Casirati
Daniele Mannina
Fabio Giglio
Carlo Messina
Mara Morelli
Francesca Lorentino
Sara Mastaglio
Tommaso Perini
Luca Vago
Paolo Scarpellini
Matteo Giovanni Carrabba
Maria Teresa Lupo Stanghellini
Sarah Marktel
Andrea Assanelli
Massimo Bernardi
Consuelo Corti
Jacopo Peccatori
Massimo Clementi
Fabio Ciceri
Nanosphere's Verigene® Blood Culture Assay to Detect Multidrug-Resistant Gram-Negative Bacterial Outbreak: A Prospective Study on 79 Hematological Patients in a Country with High Prevalence of Antimicrobial Resistance
Clinical Hematology International
Sepsis
Hematological patients
Molecular diagnosis
Carbapenem resistance
title Nanosphere's Verigene® Blood Culture Assay to Detect Multidrug-Resistant Gram-Negative Bacterial Outbreak: A Prospective Study on 79 Hematological Patients in a Country with High Prevalence of Antimicrobial Resistance
title_full Nanosphere's Verigene® Blood Culture Assay to Detect Multidrug-Resistant Gram-Negative Bacterial Outbreak: A Prospective Study on 79 Hematological Patients in a Country with High Prevalence of Antimicrobial Resistance
title_fullStr Nanosphere's Verigene® Blood Culture Assay to Detect Multidrug-Resistant Gram-Negative Bacterial Outbreak: A Prospective Study on 79 Hematological Patients in a Country with High Prevalence of Antimicrobial Resistance
title_full_unstemmed Nanosphere's Verigene® Blood Culture Assay to Detect Multidrug-Resistant Gram-Negative Bacterial Outbreak: A Prospective Study on 79 Hematological Patients in a Country with High Prevalence of Antimicrobial Resistance
title_short Nanosphere's Verigene® Blood Culture Assay to Detect Multidrug-Resistant Gram-Negative Bacterial Outbreak: A Prospective Study on 79 Hematological Patients in a Country with High Prevalence of Antimicrobial Resistance
title_sort nanosphere s verigene r blood culture assay to detect multidrug resistant gram negative bacterial outbreak a prospective study on 79 hematological patients in a country with high prevalence of antimicrobial resistance
topic Sepsis
Hematological patients
Molecular diagnosis
Carbapenem resistance
url https://www.atlantis-press.com/article/125907527/view
work_keys_str_mv AT raffaellagreco nanospheresverigenebloodcultureassaytodetectmultidrugresistantgramnegativebacterialoutbreakaprospectivestudyon79hematologicalpatientsinacountrywithhighprevalenceofantimicrobialresistance
AT mariachiarabarbanti nanospheresverigenebloodcultureassaytodetectmultidrugresistantgramnegativebacterialoutbreakaprospectivestudyon79hematologicalpatientsinacountrywithhighprevalenceofantimicrobialresistance
AT nicasiomancini nanospheresverigenebloodcultureassaytodetectmultidrugresistantgramnegativebacterialoutbreakaprospectivestudyon79hematologicalpatientsinacountrywithhighprevalenceofantimicrobialresistance
AT laurainfurnari nanospheresverigenebloodcultureassaytodetectmultidrugresistantgramnegativebacterialoutbreakaprospectivestudyon79hematologicalpatientsinacountrywithhighprevalenceofantimicrobialresistance
AT reneepasciuta nanospheresverigenebloodcultureassaytodetectmultidrugresistantgramnegativebacterialoutbreakaprospectivestudyon79hematologicalpatientsinacountrywithhighprevalenceofantimicrobialresistance
AT alessandraforcina nanospheresverigenebloodcultureassaytodetectmultidrugresistantgramnegativebacterialoutbreakaprospectivestudyon79hematologicalpatientsinacountrywithhighprevalenceofantimicrobialresistance
AT chiaraoltolini nanospheresverigenebloodcultureassaytodetectmultidrugresistantgramnegativebacterialoutbreakaprospectivestudyon79hematologicalpatientsinacountrywithhighprevalenceofantimicrobialresistance
AT gabrielecasirati nanospheresverigenebloodcultureassaytodetectmultidrugresistantgramnegativebacterialoutbreakaprospectivestudyon79hematologicalpatientsinacountrywithhighprevalenceofantimicrobialresistance
AT danielemannina nanospheresverigenebloodcultureassaytodetectmultidrugresistantgramnegativebacterialoutbreakaprospectivestudyon79hematologicalpatientsinacountrywithhighprevalenceofantimicrobialresistance
AT fabiogiglio nanospheresverigenebloodcultureassaytodetectmultidrugresistantgramnegativebacterialoutbreakaprospectivestudyon79hematologicalpatientsinacountrywithhighprevalenceofantimicrobialresistance
AT carlomessina nanospheresverigenebloodcultureassaytodetectmultidrugresistantgramnegativebacterialoutbreakaprospectivestudyon79hematologicalpatientsinacountrywithhighprevalenceofantimicrobialresistance
AT maramorelli nanospheresverigenebloodcultureassaytodetectmultidrugresistantgramnegativebacterialoutbreakaprospectivestudyon79hematologicalpatientsinacountrywithhighprevalenceofantimicrobialresistance
AT francescalorentino nanospheresverigenebloodcultureassaytodetectmultidrugresistantgramnegativebacterialoutbreakaprospectivestudyon79hematologicalpatientsinacountrywithhighprevalenceofantimicrobialresistance
AT saramastaglio nanospheresverigenebloodcultureassaytodetectmultidrugresistantgramnegativebacterialoutbreakaprospectivestudyon79hematologicalpatientsinacountrywithhighprevalenceofantimicrobialresistance
AT tommasoperini nanospheresverigenebloodcultureassaytodetectmultidrugresistantgramnegativebacterialoutbreakaprospectivestudyon79hematologicalpatientsinacountrywithhighprevalenceofantimicrobialresistance
AT lucavago nanospheresverigenebloodcultureassaytodetectmultidrugresistantgramnegativebacterialoutbreakaprospectivestudyon79hematologicalpatientsinacountrywithhighprevalenceofantimicrobialresistance
AT paoloscarpellini nanospheresverigenebloodcultureassaytodetectmultidrugresistantgramnegativebacterialoutbreakaprospectivestudyon79hematologicalpatientsinacountrywithhighprevalenceofantimicrobialresistance
AT matteogiovannicarrabba nanospheresverigenebloodcultureassaytodetectmultidrugresistantgramnegativebacterialoutbreakaprospectivestudyon79hematologicalpatientsinacountrywithhighprevalenceofantimicrobialresistance
AT mariateresalupostanghellini nanospheresverigenebloodcultureassaytodetectmultidrugresistantgramnegativebacterialoutbreakaprospectivestudyon79hematologicalpatientsinacountrywithhighprevalenceofantimicrobialresistance
AT sarahmarktel nanospheresverigenebloodcultureassaytodetectmultidrugresistantgramnegativebacterialoutbreakaprospectivestudyon79hematologicalpatientsinacountrywithhighprevalenceofantimicrobialresistance
AT andreaassanelli nanospheresverigenebloodcultureassaytodetectmultidrugresistantgramnegativebacterialoutbreakaprospectivestudyon79hematologicalpatientsinacountrywithhighprevalenceofantimicrobialresistance
AT massimobernardi nanospheresverigenebloodcultureassaytodetectmultidrugresistantgramnegativebacterialoutbreakaprospectivestudyon79hematologicalpatientsinacountrywithhighprevalenceofantimicrobialresistance
AT consuelocorti nanospheresverigenebloodcultureassaytodetectmultidrugresistantgramnegativebacterialoutbreakaprospectivestudyon79hematologicalpatientsinacountrywithhighprevalenceofantimicrobialresistance
AT jacopopeccatori nanospheresverigenebloodcultureassaytodetectmultidrugresistantgramnegativebacterialoutbreakaprospectivestudyon79hematologicalpatientsinacountrywithhighprevalenceofantimicrobialresistance
AT massimoclementi nanospheresverigenebloodcultureassaytodetectmultidrugresistantgramnegativebacterialoutbreakaprospectivestudyon79hematologicalpatientsinacountrywithhighprevalenceofantimicrobialresistance
AT fabiociceri nanospheresverigenebloodcultureassaytodetectmultidrugresistantgramnegativebacterialoutbreakaprospectivestudyon79hematologicalpatientsinacountrywithhighprevalenceofantimicrobialresistance